Karthikan Rajagopal

Years Active: 2017-2020
Publications (10 Years): 5

Genentech Inc

University of Delaware (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Genentech Inc

United States

Senior Scientist & Group Leader :: Drug Delivery

University of Pennsylvania

United States

Postdoc :: Chemical and Biomolecular Engineering

Education History

University of Delaware

United States

PHD

Publications

Purnendu K Nayak, Meghan Goode, Debby P Chang, Karthikan Rajagopal
Ectoine and Hydroxyectoine Stabilize Antibodies in Spray-Dried Formulations at Elevated Temperature and during a Freeze/Thaw Process. Molecular pharmaceutics 17 (9) (2020)
Amin Famili, Susan R Crowell, Kelly M Loyet, Danielle Mandikian, C Andrew Boswell, David Cain, Joyce Chan, Laetitia Comps-Agrar, Amrita Kamath, Karthikan Rajagopal
Hyaluronic Acid-Antibody Fragment Bioconjugates for Extended Ocular Pharmacokinetics. Bioconjugate chemistry 30 (11) (2019)
Karthikan Rajagopal, Debby Chang, Purnendu Nayak, Saeed Izadi, Thomas Patapoff, Jennifer Zhang, Robert Kelley, Alavattam Sreedhara
Trehalose Limits Fragment Antibody Aggregation and Influences Charge Variant Formation in Spray-Dried Formulations at Elevated Temperatures. Molecular pharmaceutics 16 (1) (2018)
Stijn H S Koshari, Purnendu K Nayak, Shalini Burra, Isidro E Zarraga, Karthikan Rajagopal, Yun Liu, Norman J Wagner, Abraham M Lenhoff
In Situ Characterization of the Microstructural Evolution of Biopharmaceutical Solid-State Formulations with Implications for Protein Stability. Molecular pharmaceutics 16 (1) (2018)
Amin Famili, Karthikan Rajagopal
Bio-Orthogonal Cross-Linking Chemistry Enables In Situ Protein Encapsulation and Provides Sustained Release from Hyaluronic Acid Based Hydrogels. Molecular pharmaceutics 14 (6) (2017)

Karthikan Rajagopal.css-eqlu8i{font-size:small;padding-left:4px;}